Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05580653 · ClinicalTrials.gov registry record · NA
Phase 1 Seattle Dietary Biomarkers Development Center
A NA study, sponsored by Marian Neuhouser.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05580653: Completed NA study, sponsored by Marian Neuhouser.
NCT05580653 is a NA study that has completed, run by Marian Neuhouser. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05580653, a NA study, has completed, sponsored by Marian Neuhouser.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The Seattle Dietary Biomarker Development Center (S-DBDC) aims to advance the science of measuring dietary intake by identification and validation of dietary biomarkers that improve upon self-reported diet. To accomplish this mission, the Seattle DBDC will carry out controlled feeding studies in healthy human volunteers. Metabolomics assays will be conducted on blood and urine specimens collected during the feeding studies for biomarker identification.
Interventions
- OTHER Controlled feeding study of beef and/or pinto beans
- OTHER Controlled feeding study of eggs and/or black beans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2025-04-17 |
| Phase | NA |
What the finished NCT05580653 record still lists
NCT05580653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Controlled feeding study of beef and/or pinto beans is the first listed.
NCT05580653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05580653 about?
NCT05580653 is a clinical study titled "Phase 1 Seattle Dietary Biomarkers Development Center". The Seattle Dietary Biomarker Development Center (S-DBDC) aims to advance the science of measuring dietary intake by identification and validation of dietary biomarkers that improve upon self-reported diet. To accomplish this mission, the Seattle DBDC will carry out controlled feeding studies in hea...
What is the current status of trial NCT05580653?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-02. Estimated completion is 2025-04-17.
What interventions are being tested in trial NCT05580653?
The interventions under investigation include: Controlled feeding study of beef and/or pinto beans (OTHER), Controlled feeding study of eggs and/or black beans (OTHER).
Who is sponsoring clinical trial NCT05580653?
This trial is sponsored by Marian Neuhouser, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05580653's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI